Esperion Therapeutics | ESPR - 销售和管理费用



金融业
股票价格
USD
资产
USD 462.53M
现金及等价物
USD 156.16M
销售成本
USD 27.85M
流动资产
USD 459.46M
流动负债
USD 300.36M
债务
USD 262.92M
股息收益率
0
EBIT
USD 85.23M
EBITDA
USD -9.93M
员工
240
EPS每股收益
USD 0.26
股本和储备
USD -307.93M
销售毛利
USD 140.59M
债务利息支出
USD 22.64M
利息收入
USD -0.15
贷款资金
USD 457.65M
市值
USD 584.8M
净收入
USD 61.83M
营业费用
USD 83.21M
营业利润
USD 85.23M
普通股股本
USD 245.22M
PE价格收益
129.79
税前利润
USD 63.67M
销售收入
USD 168.45M
销售和管理费用
USD 39.43M
股票
USD 104.21M
贸易债权人
USD 68.41M
应收帐款人
USD 140.19M


销售和管理费用 更改 日
AbbVie USD 3.58B 316M 2026-03
Alnylam Pharmaceuticals USD 282.51M 2.55M 2026-03
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amarin USD 18.97M 1.03M 2025-12
Amgen USD 1.58B 354M 2026-03
Biogen USD 554.3M 128.2M 2026-03
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Cipla INR 13.25B 101.8M 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 104.9M 13.17M 2026-03
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Eli Lilly USD 2.93B 198M 2026-03
Esperion Therapeutics USD 39.42M 456K 2025-12
Geron USD 35.42M 6.24M 2026-03
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 46.29M 18.35M 2026-03
Heron Therapeutics USD 23.74M 605K 2025-12
Ionis Pharmaceuticals USD 151M 21M 2026-03
Merck USD 2.67B 180M 2026-03
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Moderna USD 173M 135M 2026-03
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Pfizer USD 2.92B 1.16B 2026-03
PTC Therapeutics USD 73.89M 13.31M 2026-03
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Sanofi EUR 2.33B 419M 2026-03
Sarepta Therapeutics USD 54.03M 51.35M 2026-03
United Therapeutics USD 156.6M 34M 2026-03
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12